These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 30913933)
1. Perspectives on adjunctive use of ketamine for analgosedation during extracorporeal membrane oxygenation. Maybauer MO; Koerner MM; Maybauer DM Expert Opin Drug Metab Toxicol; 2019 May; 15(5):349-351. PubMed ID: 30913933 [TBL] [Abstract][Full Text] [Related]
2. High-Dose Sedation and Analgesia During Extracorporeal Membrane Oxygenation: A Focus on the Adjunctive Use of Ketamine. Floroff CK; Hassig TB; Cochran JB; Mazur JE J Pain Palliat Care Pharmacother; 2016; 30(1):36-40. PubMed ID: 26865321 [TBL] [Abstract][Full Text] [Related]
3. Sedation Requirements in Patients on Venovenous or Venoarterial Extracorporeal Membrane Oxygenation. Patel M; Altshuler D; Lewis TC; Merchan C; Smith DE; Toy B; Zakhary B; Papadopoulos J Ann Pharmacother; 2020 Feb; 54(2):122-130. PubMed ID: 31544474 [No Abstract] [Full Text] [Related]
4. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation. Ha MA; Sieg AC Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091 [TBL] [Abstract][Full Text] [Related]
5. Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients. Cheng V; Abdul-Aziz MH; Roberts JA; Shekar K Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):103-112. PubMed ID: 30582435 [TBL] [Abstract][Full Text] [Related]
6. Ketamine infusion for patients receiving extracorporeal membrane oxygenation support: a case series. Tellor B; Shin N; Graetz TJ; Avidan MS F1000Res; 2015; 4():16. PubMed ID: 26309726 [TBL] [Abstract][Full Text] [Related]
14. Opioid and sedative requirements in extracorporeal membrane oxygenation patients on hydromorphone versus fentanyl. Browder K; Wanek M; Wang L; Hohlfelder B Artif Organs; 2022 May; 46(5):878-886. PubMed ID: 34813116 [TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review. Himebauch AS; Kilbaugh TJ; Zuppa AF Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1133-42. PubMed ID: 27322360 [TBL] [Abstract][Full Text] [Related]
17. Analgosedation in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation Support. Crow J; Lindsley J; Cho SM; Wang J; Lantry JH; Kim BS; Tahsili-Fahadan P ASAIO J; 2022 Dec; 68(12):1419-1427. PubMed ID: 35593878 [TBL] [Abstract][Full Text] [Related]
18. A Narrative Review of the Impact of Extracorporeal Membrane Oxygenation on the Pharmacokinetics and Pharmacodynamics of Critical Care Therapies. Patel JS; Kooda K; Igneri LA Ann Pharmacother; 2023 Jun; 57(6):706-726. PubMed ID: 36250355 [TBL] [Abstract][Full Text] [Related]
19. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Shekar K; Roberts JA; Mcdonald CI; Fisquet S; Barnett AG; Mullany DV; Ghassabian S; Wallis SC; Fung YL; Smith MT; Fraser JF Crit Care; 2012 Oct; 16(5):R194. PubMed ID: 23068416 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic considerations for pediatric patients receiving analgesia in the intensive care unit; targeting postoperative, ECMO and hypothermia patients. Zeilmaker GA; Pokorna P; Mian P; Wildschut ED; Knibbe CAJ; Krekels EHJ; Allegaert K; Tibboel D Expert Opin Drug Metab Toxicol; 2018 Apr; 14(4):417-428. PubMed ID: 29623729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]